Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer.
Colorectal carcinoma is commonly associated with mutation and overexpression of p53, making this antigen a potential target for immune intervention. We analyzed humoral and proliferative immunity against p53 in the blood of patients with resected primary colorectal cancer. The majority of these patients displayed anti-p53 T helper (Th) immunity in the absence of measurable p53 specific antibody levels. The Th responses were long-lasting since they could be detected up to several years after resection of the primary tumor. In a number of cases the Th responses were highly sensitive, reflected by the recognition of naturally processed p53 protein. Our data argue that boosting of these responses in patients with minimal residual disease through p53-specific vaccination, may be employed for improving the chance of disease-free survival of these patients.
van der Burg
S H
SH
Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
de Cock
K
K
Menon
A G
AG
Franken
K L
KL
Palmen
M
M
Redeker
A
A
Drijfhout
J
J
Kuppen
P J
PJ
van de Velde
C
C
Erdile
L
L
Tollenaar
R A
RA
Melief
C J
CJ
Offringa
R
R
D000368:Aged; D000369:Aged, 80 and over; D000906:Antibodies / Q000097:blood*; D000938:Antigen-Presenting Cells / Q000502:physiology; D015179:Colorectal Neoplasms / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007156:Immunologic Memory; D008297:Male; D008875:Middle Aged; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology; D016159:Tumor Suppressor Protein p53 / Q000276:immunology*
D000906:Antibodies; D016159:Tumor Suppressor Protein p53